Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029)
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE1
A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE2
Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy
- Status
- TERMINATED
- Phase
- PHASE4
Study of Heart and Renal Protection
- Status
- COMPLETED
- Phase
- PHASE4
Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures
- Status
- COMPLETED
- Phase
- NA
A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Compare Different Intubating Doses of Zemuron in Pediatric and Adolescent Subjects Under General Anesthesia
- Status
- COMPLETED
- Phase
- PHASE3
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine
- Status
- COMPLETED
- Phase
- PHASE3
AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis
- Status
- TERMINATED
- Phase
- PHASE4
A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2
MARS - Monitored Atherosclerosis Regression Study
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3